TheraSphere With Durvalumab and Tremelimumab for HCC
- Conditions
- Interventions
- First Posted Date
- 2021-10-01
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 100
- Registration Number
- NCT05063565
- Locations
- 🇺🇸
University of Arizona- Banner Health, Tucson, Arizona, United States
🇺🇸University of California San Diego, San Diego, California, United States
🇺🇸University of California San Francisco, San Francisco, California, United States
Flexiva Pulse Registry
- Conditions
- Interventions
- First Posted Date
- 2021-08-31
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 201
- Registration Number
- NCT05027971
- Locations
- 🇺🇸
Lehigh Valley Hospital, Allentown, Pennsylvania, United States
🇺🇸AdventHealth Orlando, Orlando, Florida, United States
🇺🇸University of Miami, Miami, Florida, United States
MANDARIN (S6371)
- Conditions
- Interventions
- First Posted Date
- 2021-08-23
- Last Posted Date
- 2024-12-20
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 92
- Registration Number
- NCT05016245
- Locations
- 🇨🇳
Zhongda Hospital Southeast University, Nanjing, Jiangsu, China
Step and Walking Pattern From Cardiac Monitor Study
- Conditions
- Interventions
- First Posted Date
- 2021-07-22
- Last Posted Date
- 2023-12-13
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 40
- Registration Number
- NCT04971993
- Locations
- 🇺🇸
CentraCare Heart and Vascular Clinic, Saint Cloud, Minnesota, United States
Study to Evaluate Automated Intensity Management in Patients Undergoing a BSC SCS Temporary Trial
- Conditions
- Interventions
- First Posted Date
- 2021-06-02
- Last Posted Date
- 2024-12-06
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 21
- Registration Number
- NCT04909593
- Locations
- 🇺🇸
PCPMG Clinical Research Unit, LLC, Greenville, South Carolina, United States
Effectiveness of the SpaceOAR Vue System in Subjects With Prostate Cancer Being Treated With Stereotactic Body Radiotherapy
- First Posted Date
- 2021-05-27
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 500
- Registration Number
- NCT04905069
- Locations
- 🇺🇸
GenesisCare USA, Troy, Michigan, United States
🇺🇸Florida Urology Partners, LLC, Tampa, Florida, United States
🇺🇸Kansas University Medical Center, Kansas City, Kansas, United States
Clinical Outcomes of IVUS-guided Stenting Using the Boston Scientific Vici® Venous Stent System in Treating Patients With Chronic Non-malignant Iliofemoral Vein Obstruction
- First Posted Date
- 2021-04-23
- Last Posted Date
- 2021-11-01
- Lead Sponsor
- Boston Scientific Corporation
- Registration Number
- NCT04856592
REZŪM vs. Dual Drug Therapy for Symptomatic Benign Prostatic Hyperplasia in Sexually Active Men
- Conditions
- Interventions
- First Posted Date
- 2021-04-09
- Last Posted Date
- 2024-12-13
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 150
- Registration Number
- NCT04838769
- Locations
- 🇦🇺
Epworth Healthcare, Melbourne, Australia
🇦🇺Australian Clinical Trials, Wahroonga, Australia
🇫🇷Centre Hospitalier du Pays d'Aix, Aix-en-Provence, France
BoStOn SCientific Rhythm MAnagemenT REgiStry (SOCRATES)
- Conditions
- Interventions
- First Posted Date
- 2021-04-01
- Last Posted Date
- 2024-12-09
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 12500
- Registration Number
- NCT04823663
- Locations
- 🇧🇪
Universitair Ziekenhuis Brussel, Jette, Belgium
🇧🇪CHU UCL Namur - Site Godinne, Yvoir, Belgium
🇨🇦Institut Universitaire de Cardiologie et de Pneumologie de Quebec, Quebec City, Quebec, Canada
To Evaluate the Feasibility, Preliminary Safety and Performance of Rezūm System in BPH Treatment in China
- First Posted Date
- 2021-03-30
- Last Posted Date
- 2022-03-02
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 22
- Registration Number
- NCT04823221
- Locations
- 🇨🇳
Boao Yiling Life Care Center, Boao, Hainan, China